Combined radioimmunotherapy and radiotherapy of liver metastases from colorectal cancer: a feasibility study
Published inAnticancer research, vol. 20, no. 3B, p. 1889-1896
Publication date2000
Abstract
Keywords
- Adult
- Animals
- Antibodies, Monoclonal/adverse effects/pharmacokinetics/therapeutic use
- Bone Marrow Diseases/etiology
- Carcinoembryonic Antigen/immunology
- Colorectal Neoplasms/pathology
- Combined Modality Therapy
- Dose Fractionation
- Drug Administration Schedule
- Feasibility Studies
- Female
- Humans
- Immunoglobulin Fab Fragments/adverse effects/therapeutic use
- Iodine Radioisotopes/adverse effects/pharmacokinetics/therapeutic use
- Liver Diseases/etiology
- Liver Function Tests
- Liver Neoplasms/radiotherapy/secondary/therapy
- Male
- Mice
- Mice, Nude
- Middle Aged
- Premedication
- Radioimmunotherapy/adverse effects
- Radiotherapy Dosage
- Radiotherapy, High-Energy/adverse effects
- Tissue Distribution
- Treatment Outcome
Research group
Citation (ISO format)
BUCHEGGER, Franz et al. Combined radioimmunotherapy and radiotherapy of liver metastases from colorectal cancer: a feasibility study. In: Anticancer research, 2000, vol. 20, n° 3B, p. 1889–1896.
Main files (1)
Article (Published version)
Identifiers
- PID : unige:48439
- PMID : 10928122
ISSN of the journal0250-7005
